Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMR6GJK)

Drug Name
Butirosin B Drug Info
Synonyms
Ambuyrosin A; AC1Q5OCU; AC1L1DSB; SCHEMBL19944113; C21H41N5O12; D-Streptamine, O-2,6-diamino-2,6-dideoxy-alpha-D-glucopyranosyl-(1-4)-O-(beta-D-xylofuranosyl-(1-5))-N(sup 1)-(4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-; Butirosin A from Bacillus vitellinus; LS-16557; 4-amino-n-{5-amino-4-[(2,6-diamino-2,6-dideoxyhexopyranosyl)oxy]-2-hydroxy-3-(pentofuranosyloxy)cyclohexyl}-2-hydroxybutanamide; LS-147025
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
12302172
ChEBI ID
CHEBI:65110
CAS Number
CAS 34291-03-7
TTD Drug ID
DMR6GJK

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
Investigative Drug(s)
Download the Complete Related Drug List
Drug(s) Targeting Bacterial 16S ribosomal RNA (Bact 16S rRNA)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Framycetin DMF8DNE Acute liver failure DB91 Approved [2]
Oxazolidinones DMBM47Z Gram-positive bacterial infection 1B74-1G40 Phase 2 [3]
Apramycin DMU8QD2 Gram-negative bacterial infection 1B74-1G40 Phase 1 [1]
G418 DMKTJBU Discovery agent N.A. Investigative [1]
Hygromycin B DMEZ92A Discovery agent N.A. Investigative [1]
Ribostamycin DMXWUHA Discovery agent N.A. Investigative [1]
Neamine DMNCU6H Discovery agent N.A. Investigative [1]
Aminodeoxykanamycin DM79E2K Discovery agent N.A. Investigative [1]
⏷ Show the Full List of 8 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Bacterial 16S ribosomal RNA (Bact 16S rRNA) TT38DW5 NOUNIPROTAC Inhibitor [1]

References

1 RNA as a target for small molecules. Curr Opin Chem Biol. 2000 Dec;4(6):678-86.
2 Antistaphylococcal activity of gentamicin. Minerva Med. 1975 Dec 8;66(84):4505-26.
3 Ribosomal RNA is the target for oxazolidinones, a novel class of translational inhibitors. RNA. 1999 Jul;5(7):939-46.